Tiotropium Bromide in the Routine Care of GOLD Stage II COPD Patients: A Pharmaeconomic Evaluation

Farmeconomia. Health economics and therapeutic pathways
doi 10.7175/fe.v12i2.70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Seed SRL

Related search

Cost-Effectiveness of Aclidinium Bromide Compared With Tiotropium Bromide From the Perspective of Copd Patient Populations

International Journal of Medicine and Pharmacy
2014English

A Comparison of the BODE Index and the GOLD Stage Classification of COPD Patients in the Evaluation of Physical Ability

Journal of Physical Therapy Science
Physical TherapySports TherapyRehabilitation
2011English

Tiotropium Bromide: An Update

Open Respiratory Medicine Journal
PulmonaryRespiratory Medicine
2009English

Prevalence of Different Comorbidities in COPD Patients by Gender and GOLD Stage

Multidisciplinary Respiratory Medicine
PulmonaryRespiratory Medicine
2015English

Effect of Erdosteine on the Rate of Copd Exacerbations in Spirometrically Defined Gold Ii Patients

Respirology
PulmonaryRespiratory Medicine
2017English

Discharge Planning and Home Care for End-Stage COPD Patients

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2009English

S51 Efficacy of Aclidinium Bromide Compared With Tiotropium and Placebo in Patients With Moderate to Severe COPD: A Phase IIIb Study: Abstract S51 Table 1

Thorax
PulmonaryRespiratory Medicine
2012English

GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study

Chronic Obstructive Pulmonary Diseases
PulmonaryRespiratory Medicine
2017English

Cost-Effectiveness of Glycopyrronium Compared to Tiotropium in COPD Patients From a Swedish Societal Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy